Patients Ending the silence: Why the menopause matters in the workpla... One of the biggest challenges for women in their 40s and 50s going through the menopause is the recognition that one size does not fit all.
News Bayer sells testosterone drug rights to Grünenthal for €500m Bayer's venerable testosterone replacement product for men with hypogonadism – Nebido – is being sold to Grünenthal as the group continues a revamp of its healthcare business.